Effect of Intraoperative Dexmedetomidine on the Postoperative Quality of Recovery in the Patients Undergoing Open Cervical Spine Surgery

Effect of Intraoperative Dexmedetomidine on the Postoperative Quality of Recovery in the Patients Undergoing Open Cervical Spine Surgery: A Randomized Double-blind Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0009995

Enrollment

128

Registered

2024-12-04

Start date

2024-12-01

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : In the experimental group receiving dexmedetomidine, a maintenance dose of dexmedetomidine at 0.8 mcg/kg/h is continuously infused from the induction of anesthesia until the end of surgery. In

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult patients undergoing cervical spine surgery under general anesthesia

Exclusion criteria

Exclusion criteria: Patients who do not consent to participate in the study Patients with contraindications to the use of dexmedetomidine Patients with psychiatric disorders such as dementia or delirium Patients unable to complete the short-form Quality of Recovery questionnaire

Design outcomes

Primary

Measure	Time frame
QoR-15 score	—

Secondary

Measure	Time frame
QoR-15 score;postoperative visual analogue pain scale at rest;Time to first rescue analgesic administration after surgery;Total amount of rescue analgesic administration after surgery;Incidence and severity of postoperative side effects;Time to first ambulation;hospital stay	—

Countries

Korea, Republic of

Contacts

Public ContactWoo-young Jo

Seoul National University Hospital

jowoo345@naver.com+82-2-2072-0586

Outcome results